Recent Management and Prevention of Neutropenia Supportive Care News

Neulasta Significantly Reduces Febrile Neutropenia Among Colorectal Cancer Patients Receiving Chemotherapy Plus Avasatin

(February 25, 2013)

Neulasta® (pegfilgrastim) significantly reduced the incidence of grade 3/4 febrile neutropenia among patients with locally advanced or metastatic colorectal cancer who received chemotherapy with FOLFOX... Continue Reading


Naproxen May Relieve Bone Pain Associated with Neulasta

(August 2, 2012)

Twice-daily naproxen is effective in reducing the incidence and severity of bone pain associated with the use of Neulasta® (pegfilgrastim), according to the results of a study published in the Journal... Continue Reading


Celebrities Stand Up to Cancer

(September 14, 2009)

Celebrities and Amgen are joining forces to Stand Up to Cancer™—in the form of a public service campaign designed to educate cancer patients and caregivers about managing the increased risk of infection... Continue Reading


Amgen Helps Reduce Out-of-pocket Costs for Neulasta®

(July 3, 2009)

Amgen’s Neulasta FIRST STEP™ Program provides assistance to eligible, low-income, commercially-insured chemotherapy patients who need help with their co-insurance or co-payment requirement for Neulasta®... Continue Reading